Medical
Invest in MSLs to reap bigger gains
To get the most from MSLs pharma needs to invest, measure and empower
More Articles
Clinical
Telemedicine: The future of clinical trials?
There is a new surge of interest in telemedicine’s potential to optimize clinical trials, but is this what patients want?
Patients and Medical
Patients united: Bringing the patient voice to genetics research
Parkinson’s disease genetic research has a powerful force to hand – an army of patients
Multichannel
Five eye-openers from the MIT Healthcare Panel
Modern pharma should not underestimate the importance of experience and culture in this age of innovation in R&D and data science
Access and Evidence
Prescription drug pricing: The times they are a changin’
The political mood in the US on drug pricing at a national and state level is putting the pressure on pharma to demonstrate value
Commercial
Has direct to consumer marketing in pharma had its day?
Outmoded and cliched DTC campaigns may be harming not helping pharma in the US
Clinical
Clinical must think outside, and inside the box
From site-in-a-box to virtual/siteless trials: which new model will successfully disrupt clinical research?
Multichannel
The online health trends pharma should be tapping into
Pharma should be harnessing some powerful online trends but is it?
Medical
Taking the plunge into digital
Medical affairs is starting to expand its knowledge, reach and engagement with digital tools
Access and Evidence
Putting a price on life: Is the answer outside pharma?
Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthcare advancements suggests maybe not.